You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 24, 2024

Details for Patent: 9,012,469

✉ Email this page to a colleague

« Back to Dashboard

Which drugs does patent 9,012,469 protect, and when does it expire?

Patent 9,012,469 protects MOVANTIK and is included in one NDA.

This patent has forty-five patent family members in thirty-eight countries.

Summary for Patent: 9,012,469

Title:	Crystalline naloxol-peg conjugate
Abstract:	Naloxol-polyethlyene glycol conjugates of the formula: are provided in oxalate or phosphate salt forms including crystalline forms. Methods of preparing the salt forms and pharmaceutical compositions comprising the salt forms are also provided.
Inventor(s):	.ANG.slund; Bengt Leonard (Alderley Park, GB), Aurell; Carl-Johan (Alderley Park, GB), Bohlin; Martin Hans (Alderley Park, GB), Healy; Eric Thomas (Waltham, MA), Jensen; David Richard (Waltham, MA), Jonaitis; David Thomas (Waltham, MA), Parent; Stephan (Waltham, MA), Sebhatu; Tesfai (Alderley Park, GB), Ymen; Bo Ingvar (Alderley Park, GB)
Assignee:	AstraZeneca AB (Sodertalje, SE) Nektar Therapeutics (San Francisco, CA)
Application Number:	13/823,953
Patent Litigation and PTAB cases:	See patent lawsuits and PTAB cases for patent 9,012,469
Patent Claim Types: see list of patent claims	Compound; Use; Formulation; Composition; Dosage form;

Drugs Protected by US Patent 9,012,469

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
Valinor	MOVANTIK	naloxegol oxalate	TABLET;ORAL	204760-001	Sep 16, 2014		RX	Yes	No	⤷ Sign Up	⤷ Sign Up	Y	Y			⤷ Sign Up
Valinor	MOVANTIK	naloxegol oxalate	TABLET;ORAL	204760-002	Sep 16, 2014		RX	Yes	Yes	⤷ Sign Up	⤷ Sign Up	Y	Y			⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Patented / Exclusive Use	>Submissiondate

Foreign Priority and PCT Information for Patent: 9,012,469

PCT Information
PCT Filed	September 29, 2011	PCT Application Number:	PCT/SE2011/051161
PCT Publication Date:	April 05, 2012	PCT Publication Number:	WO2012/044243

International Family Members for US Patent 9,012,469

Subscribe to access the full database, or Sign Up
Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Argentina	083268	⤷ Sign Up
Australia	2011307608	⤷ Sign Up
Brazil	112013007113	⤷ Sign Up
Canada	2812649	⤷ Sign Up
Chile	2013000866	⤷ Sign Up
China	103237547	⤷ Sign Up
Colombia	6700851	⤷ Sign Up
>Country	>Patent Number	>Estimated Expiration	>Supplementary Protection Certificate	>SPC Country	>SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.